JP2007513180A5 - - Google Patents

Download PDF

Info

Publication number
JP2007513180A5
JP2007513180A5 JP2006542824A JP2006542824A JP2007513180A5 JP 2007513180 A5 JP2007513180 A5 JP 2007513180A5 JP 2006542824 A JP2006542824 A JP 2006542824A JP 2006542824 A JP2006542824 A JP 2006542824A JP 2007513180 A5 JP2007513180 A5 JP 2007513180A5
Authority
JP
Japan
Prior art keywords
composition
phosphatidylcholine
composition according
acid
phospholipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006542824A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007513180A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/040665 external-priority patent/WO2005055994A1/en
Publication of JP2007513180A publication Critical patent/JP2007513180A/ja
Publication of JP2007513180A5 publication Critical patent/JP2007513180A5/ja
Withdrawn legal-status Critical Current

Links

JP2006542824A 2003-12-04 2004-12-03 喘息の処置および予防 Withdrawn JP2007513180A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52678703P 2003-12-04 2003-12-04
PCT/US2004/040665 WO2005055994A1 (en) 2003-12-04 2004-12-03 Treatment and preventions of asthma

Publications (2)

Publication Number Publication Date
JP2007513180A JP2007513180A (ja) 2007-05-24
JP2007513180A5 true JP2007513180A5 (https=) 2007-12-27

Family

ID=34676656

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006542824A Withdrawn JP2007513180A (ja) 2003-12-04 2004-12-03 喘息の処置および予防

Country Status (6)

Country Link
US (1) US20070129297A1 (https=)
EP (1) EP1694314A4 (https=)
JP (1) JP2007513180A (https=)
AU (1) AU2004296206A1 (https=)
CA (1) CA2549160A1 (https=)
WO (1) WO2005055994A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5183068B2 (ja) * 2003-12-22 2013-04-17 フィンレイ，ウォーレン，エイチ 大気噴出凍結乾燥法による粉末形成
WO2005073246A2 (en) * 2004-01-20 2005-08-11 Discovery Laboratories, Inc. Method for preparing kl4 lung surfactant
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
JPWO2007001094A1 (ja) * 2005-06-29 2009-01-22 相男 李 人工肺サーファクタント組成物
WO2007005672A2 (en) * 2005-06-30 2007-01-11 The Scripps Research Institute Treatment and prevention of respiratory diseases and conditions
CN101505763A (zh) 2006-06-09 2009-08-12 鹿特丹伊拉斯姆斯大学医疗中心 通过肌醇磷脂调节免疫系统
JP2010503731A (ja) * 2006-09-19 2010-02-04 ディスカバリー ラボラトリーズ，インコーポレイテッド 肺サーファクタント製剤および粘液クリアランスの促進方法
US20100284969A1 (en) * 2007-06-05 2010-11-11 Frank Guarnieri Methods and Compositions for Delivery of Medicaments to the Lungs
CN102131827A (zh) * 2007-12-13 2011-07-20 葛兰素集团有限公司 用于肺部传递给药的组合物
WO2010068754A2 (en) * 2008-12-10 2010-06-17 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
CN102300582A (zh) 2009-01-30 2011-12-28 阿尔法贝塔公司 用于治疗阿尔茨海默病的化合物和方法
WO2010107487A2 (en) * 2009-03-18 2010-09-23 Wu Nian Lipid-drug conjugates for drug delivery
WO2011162655A1 (en) 2010-06-24 2011-12-29 Alphabeta Ab Compound and method for treatment of alzheimer's disease and familial dementia
WO2012138284A1 (en) 2011-04-05 2012-10-11 Alphabeta Ab Amyloidosis target useful in methods of treatment and for screening of compounds
WO2013081452A1 (en) 2011-11-30 2013-06-06 Erasmus University Medical Center Rotterdam Phosphatidylinositol
WO2017180546A1 (en) * 2016-04-11 2017-10-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing lung disease
US20210379141A1 (en) * 2016-04-11 2021-12-09 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing lung disease
AU2022213291B2 (en) * 2021-01-29 2025-03-13 Signpath Pharma, Inc. Lipids that reduce lung damage, improve pulmonary function and decrease pro-inflammatory cytokines
AR126368A1 (es) * 2021-07-05 2023-10-11 Chiesi Farm Spa Proceso para la preparación de un tensioactivo pulmonar

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916117A (en) * 1986-12-24 1990-04-10 John Lezdey Treatment of inflammation using alpha 1-antichymotrypsin
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US6613734B2 (en) * 1988-01-06 2003-09-02 The Scripps Research Institute Peptides-containing liposomal surfactants
US5260273A (en) * 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US6013619A (en) * 1988-01-06 2000-01-11 The Scripps Research Institute Pulmonary surfactants and therapeutic uses, including pulmonary lavage
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5707634A (en) * 1988-10-05 1998-01-13 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
US5993805A (en) * 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
US5734014A (en) * 1992-08-11 1998-03-31 Tsumura & Co. Elafin derivative
AU5171293A (en) * 1992-10-14 1994-05-09 Regents Of The University Of Colorado, The Ion-pairing of drugs for improved efficacy and delivery
US5301644A (en) * 1993-06-16 1994-04-12 Kohler Co. Fuel shut-off mechanism for internal combustion engines
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
GB9413202D0 (en) * 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
US5878912A (en) * 1995-12-26 1999-03-09 Stein; Myron Duct disinfecting method and apparatus
US5780440A (en) * 1996-06-17 1998-07-14 Protease Sciences Inc. Treatment of pulmonary disease with protease inhibitors
US6077543A (en) * 1996-12-31 2000-06-20 Inhale Therapeutic Systems Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
US6051257A (en) * 1997-02-24 2000-04-18 Superior Micropowders, Llc Powder batch of pharmaceutically-active particles and methods for making same
US5973574A (en) * 1997-04-21 1999-10-26 Eastman Kodak Company Oscillator system with corrective frequency modulation
US5833084A (en) * 1997-07-18 1998-11-10 Chang; Hsi-Te Modular rack
US6284282B1 (en) * 1998-04-29 2001-09-04 Genentech, Inc. Method of spray freeze drying proteins for pharmaceutical administration
WO2000027360A1 (en) * 1998-11-10 2000-05-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Treatment set containing lungsurfactant compositions
US6223455B1 (en) * 1999-05-03 2001-05-01 Acusphere, Inc. Spray drying apparatus and methods of use
WO2003090682A2 (en) * 2002-04-25 2003-11-06 The Scripps Research Institute Treatment and prevention of pulmonary conditions

Similar Documents

Publication Publication Date Title
JP2007513180A5 (https=)
KR101036058B1 (ko) 폐질환 증상의 치료 및 예방
AU2007297691B2 (en) Pulmonary surfactant formulations and methods for promoting mucus clearance
AU2002323266B2 (en) Method for treating lung cancers
JP2002509876A5 (https=)
PT1296663E (pt) Administração altamente eficaz de um aerosol de grande massa terapêutica
JP2005529885A5 (https=)
JP2013177422A (ja) サーファクタント処置療法
AU2002323266A1 (en) Method for treating lung cancers
US20070129297A1 (en) Treatment and prevention of asthma
WO2007005672A2 (en) Treatment and prevention of respiratory diseases and conditions
US20050058697A1 (en) Cell penetrating therapeutic agents
US20230029342A1 (en) Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
JP4767854B2 (ja) 合成界面活性剤のための新規な脂質混合物
JP2023546297A (ja) 肺治療組成物
Shah et al. Surface-active drug loaded lipopolymeric nanohybrid aerosol therapy: potential non-invasive way to mitigate lipopolysaccharide mediated inflammation in murine lungs
WO2015061412A1 (en) Methods and compositions for promoting bronchioli dilatation
WO2013188016A2 (en) Surfactant therapy for exposure to ionizing radiation
KR20250172196A (ko) 폐 계면활성제 및 항섬유화제를 포함하는 폐섬유증의 예방 또는 치료용 조성물 및 이의 제조방법